Posted on 11/24/20
Virginia Sees Significant Uptick in COVID-19 Cases, Deaths
As the coronavirus spreads dramatically across the nation, Virginia recorded 16,401 new COVID-19 cases and 136 deaths last week, a significant increase in both statistics compared . . .
Posted on 11/23/20
Qiagen: Strong Short-Term COVID Play
Summary Qiagen has been a beneficiary of COVID related tailwinds particularly as related to COVID testing, which has driven strong revenue growth and profitability.Several new products . . .
Posted on 11/23/20
COVID Collaborative Announces Partnership with Ad Council on $50 Million Vaccine Education Campaign
Today, COVID Collaborative announced a partnership with the Ad Council on an unprecedented $50 million vaccine education campaign. This initiative will represent one of the largest . . .
Posted on 11/23/20
Merck To Acquire OncoImmune For $425M
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and OncoImmune, a privately-held, clinical-stage biopharmaceutical company
Posted on 11/23/20
Better Coronavirus Stock: Moderna or Novavax?
Does big pharma dominate the coronavirus vaccine race? It might seem that way. Of the five COVID-19 vaccine candidates in late-stage testing that could be players . . .
Posted on 11/23/20
A Q&A with Dr. Samuel Hahn with MD Center for Facial Plastic Surgery
The pandemic has had a profound impact on the way the healthcare industry has operated. We sat down with
Posted on 11/18/20
Stand Together Ventures Lab Invests in AI Solution
Stand Together Ventures Lab today announced an investment in JusticeText, a software platform that makes it easier for public defenders to process and incorporate crucial audio and . . .
Posted on 11/18/20
Could Novavax Be a Millionaire-Maker Stock?
As the coronavirus vaccine race continues, investors are increasingly ditching less prominent drugmakers exhibiting slow progress and/or financial woes; Inovio Pharmaceuticals (NASDAQ:INO) and Sorrento Therapeutics (NASDAQ:SRNE) . . .
Posted on 11/17/20
Beverage Companies Urge Marylanders to Keep Recycling Especially During the Pandemic
The COVID-19 pandemic has brought about drastic changes to our daily lives. The share of products consumed, used and disposed of at home has grown – . . .
Posted on 11/17/20
Va. COVID-19 Rate Shoots Past 7%
Virginia’s COVID-19 cases continue to rise, with 11,160 new cases and 93 deaths recorded over the past week, according to the Virginia Department of Health’s Nov. . . .
Posted on 11/17/20
Novavax and Sorrento Therapeutics: Are These Beaten-Down Coronavirus Stocks a Bargain?
COVID-19 stocks have been a hot commodity in 2020. Several companies with anti-coronavirus assets such as antibodies, diagnostics, and vaccines, in fact, have seen their share . . .
Posted on 11/16/20
Is Novavax a Ticking Time Bomb for Investors?
Any time there's euphoria in investing circles, the clock starts counting down to when some hot stocks -- those that traders treated more like chips in . . .
Posted on 11/15/20
MyMD Pharmaceuticals, Akers Biosciences Merging to Form Baltimore-based Company
A merger deal between medical device companies will a result in a new Baltimore-based company with a
Posted on 11/12/20
Three Va. Labs Selected for OneLab Network
The state Department of General Services and Virginia Department of Health awarded three Virginia laboratories contracts to participate in the state’s new OneLab Network, aimed to . . .
Posted on 11/12/20
Virginia is ‘Ready’ To Distribute COVID-19 Vaccine, Governor Says
Gov. Ralph Northam and State Health Commissioner Dr. Norman Oliver said Tuesday that Virginia will be ready to launch a vaccination program as soon as a . . .
Posted on 11/10/20
Why Inovio Pharmaceuticals, Novavax, and Vaxart Crashed in October
What happenedDevelopmental-stage COVID-19 vaccine stocks continued their recent downward trend last month. Over the course of October, for instance, Inovio Pharmaceuticals (NASDAQ:INO) lost 16.1% of its . . .
Posted on 11/10/20
Novavax Reports Third Quarter 2020 Financial and Operational Results
GAITHERSBURG, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its . . .
Posted on 11/9/20
Sheppard Pratt Awarded $250,000 Grant from SunTrust Charitable Irrevocable Trust
Sheppard Pratt was awarded a $250,000 grant from the SunTrust Charitable Irrevocable Trust to pilot a workforce development project to help support jobs and promote financial . . .
Posted on 11/9/20
Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
GAITHERSBURG, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Novavax (NVAX), Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced . . .
Posted on 11/9/20
CASI Pharmaceuticals Announces Third Quarter 2020 Financial Results
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results and business highlights . . .
Posted on 11/9/20
Why Emergent BioSolutions Slipped on Friday
What happenedShareholders of vaccine and antibody therapy specialist Emergent BioSolutions (NYSE:EBS) were feeling a bit queasy on Friday afternoon. That day, the company's stock fell by . . .
Posted on 11/8/20
Howard County General Hospital Offers Community COVID-19 Testing
Howard County General Hospital will offer community COVID-19 testing for children and adults in November and December at no cost to participants. Tests will be administered . . .
Posted on 11/6/20
Is Novavax About to Achieve Warp Speed in the Coronavirus Vaccine Race?
With 11 coronavirus vaccine candidates in phase 3 trials and 49 in earlier stages, it can be hard for laypeople to estimate which has the best . . .
Posted on 11/5/20
Biogen Changes The World And Grows 44%
SummaryBiogen had a dramatic day, after years of flip-flop, as it appears the company's new Aducanumab drug will be approved.Even outside of Aducanumab, the company has . . .
Posted on 11/5/20
3 Big Advantages Novavax Has Over Moderna
Moderna (NASDAQ:MRNA) just might win FDA emergency use authorization for its COVID-19 vaccine candidate mRNA-1273 by the end of the year. Only one other coronavirus vaccine . . .
Washington DC
